Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Oncology

MA15.09 Dynamic Monitoring and Predictive Value of Circulating Tumor Cells in EGFR Mutant Advanced NSCLC Patients Treated With First-Line EGFR-TKIs

Journal of Thoracic Oncology

English

MTE05.01 Role of Pneumonectomy in N2 Disease

Journal of Thoracic Oncology

English

P3.01-40 Treatment of Super Elderly Patients for Non-Small Cell Lung Cancer in Japan

Journal of Thoracic Oncology

English

P3.01-42 Phase II Trial Allowed Surgery After Induction Chemotherapy of CBDCA+PTX, Bevacizumab in Patients With Stages IIIA-IV Nonsquamous NSCLC

Journal of Thoracic Oncology

English

P2.11-08 Tumor Autoantibody Panel Can Improve the Accuracy of Early Diagnosis in Lung Cancer Presenting With GGNs /Solid Nodules

Journal of Thoracic Oncology

English

P3.01-28 the Clinical Impact of Comprehensive cfDNA Genomic Testing in Lung Cancer

Journal of Thoracic Oncology

English

MA17.01 a Sense of Understanding and Belonging When Life Is at Stake – Operable Lung Cancer Patients’ Lived Experiences of Participation in Exercise

Journal of Thoracic Oncology

English

P2.13-07 CUX1-ALK: A Novel ALK Rearrangement That Responds to Crizotinib in Non-Small-Cell Lung Cancer

Journal of Thoracic Oncology

English

Identification of EML4-ALK Rearrangement and MET Exon 14 R988C Mutation in a Patient With High-Grade Neuroendocrine Lung Carcinoma Who Experienced a Lazarus Response to Crizotinib

Journal of Thoracic Oncology

English

P3.01-11 Depression and Inflammation in Patients With EGFR-Mutated Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Oncology

MA15.09 Dynamic Monitoring and Predictive Value of Circulating Tumor Cells in EGFR Mutant Advanced NSCLC Patients Treated With First-Line EGFR-TKIs

MTE05.01 Role of Pneumonectomy in N2 Disease

P3.01-40 Treatment of Super Elderly Patients for Non-Small Cell Lung Cancer in Japan

P3.01-42 Phase II Trial Allowed Surgery After Induction Chemotherapy of CBDCA+PTX, Bevacizumab in Patients With Stages IIIA-IV Nonsquamous NSCLC

P2.11-08 Tumor Autoantibody Panel Can Improve the Accuracy of Early Diagnosis in Lung Cancer Presenting With GGNs /Solid Nodules

P3.01-28 the Clinical Impact of Comprehensive cfDNA Genomic Testing in Lung Cancer

MA17.01 a Sense of Understanding and Belonging When Life Is at Stake – Operable Lung Cancer Patients’ Lived Experiences of Participation in Exercise

P2.13-07 CUX1-ALK: A Novel ALK Rearrangement That Responds to Crizotinib in Non-Small-Cell Lung Cancer

Identification of EML4-ALK Rearrangement and MET Exon 14 R988C Mutation in a Patient With High-Grade Neuroendocrine Lung Carcinoma Who Experienced a Lazarus Response to Crizotinib

P3.01-11 Depression and Inflammation in Patients With EGFR-Mutated Non-Small Cell Lung Cancer